Inventor · disambiguated record
Lloyd Tillman
Also filed as: TILLMAN LLOYD · TILLMAN LLOYD G · TILLMAN LLOYD GARY
8 granted patents·8 pending applications·500 citations·filing 1996–2021
89Inventor score
Files withISIS PHARMACEUTICALS INC7IONIS PHARMACEUTICALS INC3ASTRAZENECA AB1GLAXO WELLCOME INC1SMITHKLINE BEECHAM CORP1
Top patents by PatentIndex Score
16 records- 0198US6747014B2Compositions and methods for non-parenteral delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2001·Granted Jun 8, 2004·356 cites·10 claims
- 0297US8691785B2Compositions and methods for non-parenteral delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 8, 2014·48 cites·13 claims
- 0389US10174318B2Antisense oligonucleotide compositionsIONIS PHARMACEUTICALS INC·Filed 2016·Granted Jan 8, 2019·3 cites·20 claims
- 0483US8377897B2Compositions and methods for non-parenteral delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2005·Granted Feb 19, 2013·6 cites·9 claims
- 0581US7576067B2Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorptionISIS PHARMACEUTICALS INC·Filed 2004·Granted Aug 18, 2009·16 cites·25 claims
- 0678US5879706AValaciclovir tablets containing colloidal silicon dioxideGLAXO WELLCOME INC·Filed 1996·Granted Mar 9, 1999·53 cites·28 claims
- 0773US11859180B2Antisense oligonucleotide compositionsIONIS PHARMACEUTICALS INC·Filed 2020·Granted Jan 2, 2024·0 cites·20 claims
- 0870US2019316123A1Antisense oligonucleotide compositionsIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0964US2016002624A1Antisense oligonucleotide compositionsISIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1061US2011256217A1Pulsatile release compositions and methods for enhanced intestinal drug absorptionISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1157US2004229831A1Compositions and methods for non-parenteral delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1254US6730679B1Pharmaceutical formulationsSMITHKLINE BEECHAM CORP·Filed 1997·Granted May 4, 2004·18 cites·21 claims
- 1350US2023357768A1Pharmaceutical compositions comprising an antisense oligonucleotide for oral administrationASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 1447US2003027780A1Multiparticulate formulationFiled 2002·Application pending·0 cites
- 1545US2003124196A1Pulsatile release compositions and methods for enhanced intestinal drug absorptionFiled 2001·Application pending·0 cites
- 1638US2003083286A1Bioadhesive compositions and methods for enhanced intestinal drug absorptionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lloyd Tillman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →